{
  "id": 657879,
  "title": "New Tufts CSDD Analysis Finds AI Agents Can Deliver Up to $21 Million in Net Financial Value Per Drug Development Program and Up to 82x ROI",
  "url": "https://urgent.news/2026/08/12/new-tufts-csdd-analysis-finds-ai-agents-can-deliver-up-to-21-million",
  "topic": "ai",
  "section": "AI",
  "published": "2026-08-12T11:06:02.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/pmn/business-wire-news-releases-pmn/new-tufts-csdd-analysis-finds-ai-agents-can-deliver-up-to-21-million-in-net-financial-value-per-drug-development-program-and-up-to-82x-roi"
  },
  "original_language": "en",
  "account": null,
  "summary": "PALO ALTO, Calif. — Medable Inc., the leading technology platform for agentic clinical development, today announced a new Tufts Center for the Study of Drug Development (CSDD) analysis showing that an AI clinical monitoring agent can deliver net financial gains as high as $21 million per drug development program and 82 times the return on […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}